BATTICCIOTTO, ALBERTO
BATTICCIOTTO, ALBERTO
Universita' degli Studi di MILANO
Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis
2021 A. Zabotti, O. De Lucia, G. Sakellariou, A. Batticciotto, G. Cincinelli, I. Giovannini, L. Idolazzi, G. Maioli, I. Tinazzi, D. Aletaha, S. De Vita, A. Marchesoni, J. Smolen, A. Iagnocco, D. Mcgonagle, R. Caporali
Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients
2021 F. Salaffi, M. Di Carlo, L. Bazzichi, F. Atzeni, M. Govoni, G. Biasi, M. Di Franco, F. Mozzani, E. Gremese, L. Dagna, A. Batticciotto, F. Fischetti, R. Giacomelli, S. Guiducci, G. Guggino, M. Bentivegna, R. Gerli, C. Salvarani, G. Bajocchi, M. Ghini, F. Iannone, V. Giorgi, S. Farah, M. Cirillo, S. Bonazza, S. Barbagli, C. Gioia, D. Santilli, A. Capacci, G. Cavalli, F. Carubbi, F. Nacci, I. Riccucci, L. Sinigaglia, M. Masullo, B. Polizzi, M. Cutolo, P. Sarzi-Puttini
The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome
2021 F. Salaffi, V. Giorgi, S. Sirotti, S. Bongiovanni, S. Farah, L. Bazzichi, D. Marotto, F. Atzeni, M. Rizzi, A. Batticciotto, G. Lombardi, M. Galli, P. Sarzi-Puttini
One year in review 2020: fibromyalgia
2020 L. Bazzichi, C. Giacomelli, A. Consensi, V. Giorgi, A. Batticciotto, M. Di Franco, P. Sarzi-Puttini
Systemic rheumatic diseases : from biological agents to small molecules
2019 P. Sarzi-Puttini, A. Ceribelli, D. Marotto, A. Batticciotto, F. Atzeni
Evaluation of salivary and plasma microRNA expression in patients with Sjögren's syndrome, and correlations with clinical and ultrasonographic outcomes
2019 R. Talotta, V. Mercurio, S.F. Bongiovanni, C. Vittori, L. Boccassini, F. Rigamonti, A. Batticciotto, F. Atzeni, D. Trabattoni, P. Sarzi-Puttini, M. Biasin
Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis : 52-Week Results from the CZP-SPEED Study
2018 P. Sarzi-Puttini, E. Filippucci, S. Adami, P.L. Meroni, A. Batticciotto, L. Idolazzi, O. De Lucia, P. Talavera, T. Kumke, W. Grassi
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
2018 R. Talotta, F. Atzeni, A. Batticciotto, M.C. Ditto, M.C. Gerardi, P. Sarzi-Puttini
The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis
2017 F. Salaffi, M.C. Gerardi, F. Atzeni, A. Batticciotto, R. Talotta, A. Draghessi, M. Di Carlo, P. Sarzi-Puttini
Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis : a 6-month real-life observational study
2017 M. Benucci, F.L. Gobbi, F. Bandinelli, A. Damiani, M. Infantino, V. Grossi, M. Manfredi, S. Parisi, E. Fusaro, A. Batticciotto, P. Sarzi-Puttini, F. Atzeni, F. Meacci
The immunogenicity of branded and biosimilar infliximab in rheumatoid arthritis according to Th9-related responses
2017 R. Talotta, A. Berzi, A. Doria, A. Batticciotto, M.C. Ditto, F. Atzeni, P. Sarzi-Puttini, D. Trabattoni
One year in review 2017 : fibromyalgia
2017 R. Talotta, L. Bazzichi, M. Di Franco, R. Casale, A. Batticciotto, M.C. Gerardi, P. Sarzi-Puttini
Measurement of Serum Klotho in Systemic Sclerosis
2017 R. Talotta, S. Bongiovanni, T. Letizia, F. Rigamonti, M.C. Ditto, F. Atzeni, F. Salaffi, A. Batticciotto, M.C. Gerardi, M. Antivalle, T. Vago, M. Benucci, P. Sarzi-Puttini
An update on emerging drugs for fibromyalgia treatment
2017 F. Atzeni, M.C. Gerardi, I.F. Masala, A. Alciati, A. Batticciotto, P. Sarzi-Puttini
Low risk of hepatitis B virus reactivation in HBsAg-negative/anti-HBc-positive carriers receiving rituximab for rheumatoid arthritis : a retrospective multicenter Italian study
2016 V. Varisco, M. Viganò, A. Batticciotto, P. Lampertico, A. Marchesoni, P. Gibertini, R. Pellerito, G. Rovera, R. Caporali, M. Todoerti, M. Covelli, A. Notarnicola, F. Atzeni, P. Sarzi-Puttini
Infections and Biological Therapy in Patients with Rheumatic Diseases
2016 F. Atzeni, A. Batticciotto, I.F. Masala, R. Talotta, M. Benucci, P. Sarzi-Puttini
Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate
2016 A. Batticciotto, R. Ravasio, M. Riva, P. Sarzi-Puttini
Possible relationship between certolizumab pegol and arrhythmias : Report of two cases
2016 R. Talotta, F. Atzeni, A. Batticciotto, D. Ventura, P. Sarzi-Puttini
One year in review 2016 : fibromyalgia
2016 L. Bazzichi, C. Giacomelli, A. Consensi, F. Atzeni, A. Batticciotto, M. Di Franco, R. Casale, P. Sarzi-Puttini
Erratum: Hidden musculoskeletal involvement in inflammatory bowel disease : a multicenter ultrasound study(BMC Musculoskelet Disord. (2016) 17(84) 10.1186/s12891-016-0932-z)
2016 J. Rovisco, C. Duarte, A. Batticciotto, P. Sarzi-Puttini, A. Draghessi, F. Portela, M. Gutierrez